PHOENIX, AZ / ACCESSWIRE / June 24, 2019 / The Stock Day Podcast welcomed US Nuclear Corp. (OTC PINK: UCLE) (“the Company”), a company that designs, manufactures and markets branded, full line radiation and chemical detection and specialized advanced tritium technology for the nuclear energy industry, medical and for emerging technological processes. President and CEO, Bob Goldstein, joined Stock Day host Everett Jolly.

Jolly began the interview by noting that the Company’s DroneRad sales have increased by 777% over 2018. Goldstein explained that this aspect of the Company is continuing to increase and that an even higher increase is expected for 2019.

Jolly then asked Goldstein to expand on the Company’s expected DroneRad sales throughout 2019. Goldstein shared that the Company expects to have a 2,000% increase over 2018 sales, as orders continue to flow in.

Goldstein then explained the Company’s CBRN detection system, which stands for “Chemical Biological Radiation Nuclear”. He further explained that the Company chose these segments based on the dangers they pose and the interest shown by first responders, military personnel, and border security. The DroneRads are now equipped with sensors for these threats, which can tell whether or not the compounds are present in the air.

Jolly then asked whether or not third-world countries have shown interest in the Company’s products. Goldstein stated that the interest has been tremendous in these areas, especially when it comes to testing drinking water for dangerous compounds. “We can improve health and expand supply of known safe drinking water by measuring the various toxic materials in drinking water, lakes, rivers, and in industrial waste.”, explained Goldstein.

Jolly followed by noting that the Company has incredible vision, as shown by their expanding portfolio. Goldstein shared that the Company’s recent expansions have allowed them to greatly increase their available technologies, including recent developments in the medical isotope space and electric power grid space.

Jolly then asked about the Company’s recent addition to their management team, Richard Landry. Goldstein explained that Landry has an investment banking background, as well as a physics background, and is a valuable member of their team. “He’s quite experienced and sees a big future for US Nuclear Corp., and he’s come here to help us achieve it.”, stated Goldstein.

To hear Bob Goldstein entire interview, follow the link to the podcast here: https://audioboom.com/posts/7294945-ceo-robert-goldstein-of-us-nuclear-corp-otcpink-ucle-june-19-update

Investors
Hangout is a proud sponsor of “Stock Day,” and Stock Day Media encourages listeners to visit the company’s message board at https://investorshangout.com/

About US Nuclear Corp.

US Nuclear Corp is a fully-reporting, publicly traded company on the Over-the-Counter Bulletin Board, traded under the ticker symbol UCLE. The Company’s operations are principally engaged through its subsidiaries, operating two leading nuclear radiation detection companies, Overhoff Technology Corp. and Optron Scientific Company Inc. The Company designs, manufactures and markets branded, full line radiation detection and specialized advanced tritium technology for the nuclear energy industry and for emerging technological processes such as Thorium and Molten Salt (MSR) reactor technologies both domestically and internationally to customers such as United States Government Agencies, the U.S. Military, Homeland Security, Scientific Laboratories, Universities, Hospitals, nuclear reactor facilities in the United States, China, Canada, South Korea, Argentina, Russia, and others.

Safe Harbor Act

This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

Investors may find additional information by visiting US Nuclear Corp. and the SEC website.

CONTACT:

US Nuclear Corp. (UCLE)

Robert I. Goldstein, President, CEO, and Chairman

Ph: (818) 883 7043 | Email: info@usnuclearcorp.com

About The “Stock Day”
Podcast

Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America. Stock Day recently launched its Video Interview Studio located in Phoenix, Arizona.

602-441-3474

SOURCE: Stock Day Podcast

ReleaseID: 549562

New technology enables MSC Software to significantly decrease time-to-print for Additive Manufacturing

COBHAM, ENGLAND / ACCESSWIRE / June 24, 2019 / Hexagon’s Manufacturing Intelligence division today announced that Hexagon has entered into a definitive agreement to acquire AMendate, a German-based start-up providing simulation software solutions that support the generation and optimisation of designs for additive manufacturing. AMendate will join Hexagon’s MSC Software business, a global leader in computer-aided engineering (CAE) simulation software and services.

With this acquisition, MSC is positioned to offer its customers a paradigm shift away from general purpose optimisation technologies to an innovative, purpose-built software solution for additive manufacturing. Enabling the efficient production of highly complex components and providing customers with numerous benefits, from material-saving, weight reduction and efficient, cost-effective production. AMendate’s technology eliminates the inefficient manual effort that significantly slows today’s workflows, allowing work steps to be completed in days that would otherwise take several weeks.

“The AMendate acquisition directly addresses a major obstacle during design for companies shifting to additive manufacturing processes,” said Paolo Guglielmini, CEO, MSC Software. “It enhances our Smart Factory solutions by minimising time-to-print. We are proud to welcome AMendate to the MSC team, and we look forward to what we will accomplish together.”

“With MSC being one of the most renowned developers for software solutions in CAE, we are incredibly excited to introduce our generative design technology to its customers,” said Dr. Thomas Reiher, CEO & Co-Founder, AMendate GmbH. “The integration of AMendate’s software in MSC’s established simulation technologies such as Simufact and MSC Apex will enable us to further enhance our technology even faster and make its benefits available to a global audience.”

AMendate was founded in 2018 by a team of experienced researchers from Paderborn University and the Direct Manufacturing Research Center (DMRC) in Paderborn, an industrial/academic consortium started in 2008 by Boeing, EOS, and other commercial partners.

The AMendate transaction is expected to close early third quarter and subject to customary closing conditions.

About Hexagon’s Manufacturing Intelligence Division

Hexagon is a global leader in sensor, software and autonomous solutions. We are putting data to work to boost efficiency, productivity, and quality across industrial, manufacturing, infrastructure, safety, and mobility applications.

Our technologies are shaping urban and production ecosystems to become increasingly connected and autonomous – ensuring a scalable, sustainable future.

Hexagon’s Manufacturing Intelligence division provides solutions that utilise data from design and engineering, production and metrology to make manufacturing smarter. For more information, visit hexagonmi.com.

Hexagon has approximately 20,000 employees in 50 countries and net sales of approximately 3.8bn EUR. Learn more at hexagon.com and follow us @HexagonAB.

Your regional media contact:

Mary Harrison, MSC Software
Tel: +44 7741 524129
Email: mary.harrison@mscsoftware.com

SOURCE: Hexagon Manufacturing Intelligence

ReleaseID: 549647

Newly Appointed Chief Commercial Officer (CCO) Renaud Maloberti to Showcase ENDRA’s Breakthrough Thermo Acoustic Enhanced UltraSound (TAEUS) Technology Addressing Fatty Liver Disease

ANN ARBOR, MI / ACCESSWIRE / June 24, 2019 / ENDRA Life Sciences Inc. (“ENDRA”) (NASDAQ: NDRA), a developer of enhanced ultrasound technologies, will attend the 2nd International Conference on Fatty Liver, ICFL 2019, occurring June 27-29, 2019 in Berlin, Germany. At the conference, Renaud Maloberti, ENDRA Life Sciences Chief Commercial Officer will showcase ENDRA’s TAEUS™ Technology, a next generation Thermo-Acoustic Enhanced UltraSound (TAEUS™) platform that enables clinicians to visualize human tissue composition, function and temperature in ways previously possible only with CT and MRI.

ICFL 2019 will explore the clinical needs and best practices for diagnosing and treating Fatty Liver Disease. Attendees include clinicians, researchers and healthcare professionals in the field of Hepatology, Gastroenterology, as well as Diabetology, Nutrition, Radiology and Cardiology.

“I am very excited to showcase our TAEUS technology in Berlin, one of our targeted commercial rollout territories,” said Renaud Maloberti, ENDRA’s CCO. “TAEUS addresses a large unmet clinical need in liver disease and we are honored to showcase our disruptive technology with key thought leaders at ICFL 2019. We look forward to developing and furthering clinical relationships and collecting valuable feedback from radiologists, gastroenterologists, hepatologists and endocrinologists in the liver space.”

The International Conference on Fatty Liver explores the rising rate of fatty liver disease from a multidisciplinary approach. Key themes presented during the conference are:

Clinical needs and best practices for diagnosing and treating Fatty Liver;
Holistic approach to improve diagnostics tools and therapeutic modalities between disciplines;
Sharing data and experience by building a multidisciplinary international community;
Inviting leading experts across the relevant fields to educate and foster knowledge exchange; and
Hosting technology providers to present product information and trends that support their clinical and scientific practices.

About ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc. (“ENDRA”) (NASDAQ: NDRA) is a developer of enhanced ultrasound technologies. ENDRA is developing a next generation Thermo-Acoustic Enhanced UltraSound (TAEUS™) platform to enable clinicians to visualize human tissue composition, function and temperature in ways previously possible only with CT & MRI – at a fraction of the cost, and at the point-of-care. ENDRA’s first TAEUS application will focus on the fatty liver tissue characterization, for early detection and monitoring of Non-Alcoholic Fatty Liver Disease (NAFLD). ENDRA’s goal is to bring new capabilities to ultrasound – thereby broadening access to better healthcare. For more information, please visit www.endrainc.com.

About Non-Alcoholic Fatty Liver Disease (NAFLD)

NAFLD is a condition closely associated with obesity, diabetes, hepatitis-C and certain genetic predispositions in which fat accumulates in the liver. NAFLD affects over 1 billion people globally and is estimated to cost the U.S healthcare system over $100 billion annually. NAFLD is often asymptomatic and if left untreated, NAFLD can progress to inflammation (NASH), tissue scarring (fibrosis), cell death (cirrhosis) and liver cancer. By 2025, NAFLD is forecast to be the greatest root cause of liver transplants. The only tools currently available for diagnosing and monitoring NAFLD are impractical: expensive Magnetic Resonance Imaging (MRI) or an invasive surgical biopsy.

Forward-Looking Statements

All statements in this release that are not based on historical fact are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as “believe,” “expect,” “may,” “will,” “should,” “could,” “seek,” “intend,” “plan,” “goal,” “estimate,” “anticipate” or other comparable terms. Examples of forward-looking statements include, among others, statements we make regarding the results of pending human studies and nature of the data obtained from such studies; the adequacy of protections afforded to us by the patents that we own and the success we may have in, and the cost to us of, maintaining, enforcing and defending those patents; expectations concerning ENDRA’s ability to secure regulatory approvals; estimates of the timing of future events and achievements, including obtaining a CE Mark and commercializing the TAEUS device; and expectations concerning ENDRA’s business strategy. Forward-looking statements involve inherent risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements, as a result of various factors including, among others, the following: our ability to develop a commercially feasible technology; receipt of necessary regulatory approvals; our ability to find and maintain development partners, market acceptance of our technology, the amount and nature of competition in our industry; our ability to protect our intellectual property; and the other risks and uncertainties described in ENDRA’s filings with the Securities and Exchange Commission. The forward-looking statements made in this release speak only as of the date of this release, and ENDRA assumes no obligation to update any such forward-looking statements to reflect actual results or changes in expectations, except as otherwise required by law.

Company Contact:

David Wells
Chief Financial Officer
(734) 997-0464
investors@endrainc.com
www.endrainc.com

Media & Investor Relations Contact:

MZ North America
Chris Tyson
Managing Director
(949) 491-8235
NDRA@mzgroup.us
www.mzgroup.us

SOURCE: ENDRA Life Sciences Inc.

ReleaseID: 549529

PHOENIX, AZ / ACCESSWIRE / June 24, 2019 / The Stock Day Podcast welcomed High Tide, Inc. (HITIF) (“the Company”), an Alberta-based, retail-focused cannabis corporation enhanced by the manufacturing and wholesale distribution of smoking accessories and cannabis lifestyle products. Chief Strategy Officer and SVP of Capital Markets, Nick Kuzyk, joined Stock Day host Everett Jolly.

Jolly began the interview by asking Kuzyk to give listeners some background information about the Company. Kuzyk explained that High Tide, Inc. is a holding company with five operating businesses and is currently expanding into an additional business. The Company is broken into two segments, a wholesale division, and a retail division.

Jolly then asked Kuzyk what makes the Company stand out among other competitors in the market. Kuzyk explained that the Company has had a significant 10-year head start over other retail competitors, allowing them to understand their customers and develop products that are suitable for their audience. He further added that the Company currently has 31 branded stores, as well as their wholesale segment which handles all of its own manufacturing and distribution of smoking accessories.

Jolly followed by asking about the Company’s partnership with Grasscity. Kuzyk explained that acquiring this business added significant value. Grasscity is also responsible for many of the Company’s United States- based sales, which is helping the Alberta headquartered company expand globally.

Jolly inquired about the Company’s impressive revenues and how they were achieved. Kuzyk shared that the boosted revenue was achieved through the Grasscity acquisition, as well as the growth in the Company’s retail segment. He added that these revenues are expected to continually increase as the Company expands and the retail cannabis landscape grows.

Kuzyk then shared more insight into the Company’s expansion plan, which includes increasing their number of outlets across Canada. “In the next two years, we expect to exceed 100 locations in Canada.” stated Kuzyk. He added that the Company will also be expanding their wholesale division and continue to sell to B2B and B2C customers around the world.

To close the interview, Kuzyk explained that High Tide, Inc. is a company that manages its costs, current operations and expansion plans carefully. “This is a company that is proven and there is a very bright future ahead.”, closed Kuzyk.

To hear Nick Kuzyk’s entire interview, follow the link to the podcast here: https://audioboom.com/posts/7294943-ceo-nick-kuzyk-of-high-tide-inc-otcqb-hitif.

Investors Hangout is a proud sponsor of “Stock Day,” and Stock Day Media encourages listeners to visit the company’s message board at https://investorshangout.com/.

About High Tide Inc.

High Tide is an Alberta-based, retail-focused cannabis corporation enhanced by the manufacturing and wholesale distribution of smoking accessories and cannabis lifestyle products. It is a vertically-integrated company in the Canadian cannabis market, with portfolio subsidiaries including RGR Canada Inc., Famous Brandz Inc., Kush West Distribution Inc., Smoker’s Corner Ltd., Grasscity.com, Canna Cabana Inc. and the majority of KushBar Inc. High Tide’s strategy as a parent company is to extend and strengthen its integrated value chain while providing a complete customer experience and maximizing shareholder value. Key industry investors in High Tide include Aphria Inc. (APHA.TO) (APHA), Aurora Cannabis Inc. (ACB) (ACB.TO) and FSD Pharma Inc. (CSE:HUGE) (FSDDF) (0K9.F).

Representing the core of High Tide’s business, RGR Canada Inc. is a high-quality and innovative designer, manufacturer and distributor of cannabis accessories. Famous Brandz Inc. is a dominant manufacturer of licensed lifestyle accessories, through partnerships with celebrities and entertainment companies including Snoop Dogg and Paramount Pictures. Famous Brandz’ products are sold to wholesalers and retailers around the world. Founded in 2009 and approved by the Canadian Franchise Association, Smoker’s Corner Ltd. is among Canada’s largest counter-culture chains with 14 locations. Kush West Distribution is in the process of becoming a cannabis wholesaler in the province of Saskatchewan. Based in Amsterdam since 2000, Grasscity.com is the world’s preeminent and most searchable online retailer of smoking accessories and cannabis lifestyle products with approximately 5.8 million site visits annually. With the deregulation of recreational cannabis for adult use across Canada, Canna Cabana Inc., with 17 currently-branded locations, is in the process of becoming a sizeable retail brand with a sophisticated yet playful customer experience, while KushBar Inc. is a retail concept that will also be focused on the valued Canadian cannabis consumer.

For more information about High Tide Inc., please visit www.hightideinc.com and its profile page on SEDAR at www.sedar.com.

Forward-Looking Information

Certain statements in this news release are forward-looking information or forward-looking statements. Such information and statements referred to herein as “forward-looking statements” are made as of the date of this news release or as of the date of the effective date of information described in this news release, as applicable. Forward-looking statements relate to future events or future performance and reflect current estimates, predictions, expectations or beliefs regarding future events. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (generally, forward-looking statements can be identified by use of words such as “outlook”, “expects”, “intend”, “forecasts”, “anticipates”, “plans”, “projects”, “estimates”, “envisages, “assumes”, “needs”, “strategy”, “goals”, “objectives”, or variations thereof, or stating that certain actions, events or results “may”, “can”, “could”, “would”, “might”, or “will” be taken, occur or be achieved, or the negative of any of these terms or similar expressions, and other similar terminology) are not statements of historical fact and may be forward-looking statements.

Such forward-looking statements are based on assumptions that may prove to be incorrect, including but not limited to the ability of High Tide to execute on its business plan and that High Tide will receive one or multiple licenses from Alberta Gaming, Liquor & Cannabis, British Columbia’s Liquor Distribution Branch, Liquor, Gaming and Cannabis Authority of Manitoba, Alcohol and Gaming Commission of Ontario or the Saskatchewan Liquor and Gaming Authority permitting it to carry on its Canna Cabana Inc. and KushBar Inc. businesses. High Tide considers these assumptions to be reasonable in the circumstances. However, there can be no assurance that any one or more of the government, industry, market, operational or financial targets as set out herein will be achieved. Inherent in the forward-looking statements are known and unknown risks, uncertainties and other factors that could cause actual results, performance or achievements, or industry results, to differ materially from any results, performance or achievements expressed or implied by such forward-looking statements.

The forward‐looking statements contained herein are current as of the date of this news release. Except as required by law, High Tide does not have any obligation to advise any person if it becomes aware of any inaccuracy in or omission from any forward-looking statement, nor does it intend, or assume any obligation, to update or revise these forward-looking statements to reflect new events or circumstances. Any and all forward-looking statements included in this news release are expressly qualified by this cautionary statement, and except as otherwise indicated, are made as of the date of this news release.

About The “Stock Day” Podcast

Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America. Stock Day recently launched its Video Interview Studio located in Phoenix, Arizona.

602-441-3474

SOURCE: Stock Day Podcast

ReleaseID: 549561

VANCOUVER, BC / ACCESSWIRE / June 24, 2019 / EastWest Bioscience (the “Company” or “EastWest”) (TSX.V: EAST) announces that it has partnered with Avafina Pet Products (“Avafina”) (www.avafinapet.com) to distribute its Natural Pet Science line of pet treats into more than 300 stores across Western Canada. Avafina’s passionate and knowledgeable sales professionals, along with their distribution centre in Coquitlam, BC, provides a strategic distribution and sales partnership into the independent and retail chain channel for EastWest. Avafina’s customer base includes strong independent pet food retailers along with some of the largest growing pet chains in Canada. (Bone & Biscuits, Tail Blazers, and Global Pet Foods).

“We are very excited to have our growing Natural Pet Science SKUs represented in Western Canada by the Avafina team. Having a company that shares our values on supporting the health of our furry family members, and considering our treats to be just that, is absolutely fabulous! We look forward to growing with Avafina Pet for a long time to come.” says Fanika Jovanovic Perika, Global Business Development Leader, EastWest Bioscience.

The first PO has been received and will be in the Avafina Pet Products warehouse by the end of June.

About Avafina Pet Products

Avafina Pet Products is passionate about representing the best possible quality of pet products available – they wish to contribute to the overall success of their customers and the to the wellbeing of all beloved pets believing that pets are a part of our family and that their needs are important. Avafina takes great pride in serving customers with an educated sales force as well as a friendly staff dedicated to customer service. With twenty years of experience in the business, founder and CEO Kelvin DuBois says, “We are very proud of what we do and how we do it. Avafina is excited about this new partnership with EastWest.”

About Natural Pet Science

Natural Pet Science is a hemp-based pet brand producing, manufacturing and distributing premium health products for cats and dogs. The brand continues to innovate and produce high-quality hemp-based alternatives to support the preventive care of pets. For more information on Natural Pet Science, please visit www.naturalpetscience.com.

About EastWest Bioscience Group

EastWest Bioscience is a vertically integrated wellness company with the infrastructure to become a global giant in the Hemp & CBD consumer health market. Since it was founded in 2016, EastWest continues to grow as a high-quality producer, manufacturer and distributor of multiple lines of premium health and hemp products. EastWest currently has more than 200+ NPN’s in its stable of products.

EastWest’s consumer product lines are divided into four distinct brands: 1) Natural Advancement – natural biopharmaceutical health supplements; 2) Earth’s Menu – all-natural hemp superfoods; 3) Natural Pet Science – pet food and pet supplements; and 4) ChanvreHemp – all-natural health and beauty products.

In Canada, EastWest has a 34,000 Sq. Ft, Health Canada-licensed, GMP (Good Manufacturing Practices) – certified manufacturing facility and produces premium nutraceutical brands, offering natural products for a preventive care lifestyle. EastWest and Benchmark Botanicals (BBT-CSE) also have a Joint Venture Intent to accelerate acquisition of Processor, Analytical and Research and Development licenses under the Cannabis Act in EastWest’s Penticton facility. These three classes of the Cannabis Act license will allow Benchmark and EastWest to build out an extensive extraction, laboratory, and research facility at EastWest’s Health Canada Certified facility.

In the USA, EastWest USA has a Joint Venture with Azema Sciences, securing for EastWest first rights on Azema’s output of bulk CBD and finished CBD products manufactured, and which are ready for sale in the USA and globally. EastWest Science USA (“EastWest USA”), EastWest’s US operating division, will be the preferred distributor for Azema’s finished goods. These finished products will include CBD creams, tinctures and salves which are products not currently in EastWest’s catalogue. Additionally, EastWest will have first right of refusal to all potential opportunities relating to Azema’s Kentucky based CBD processing facility. EastWest currently has TSX Approval for sale of its consumer products in 21 US States.

EastWest’s international expansion continues with reach into important key markets in New Zealand, Australia, and Asia through a distributor agreement with New Zealand Hemp Brokers. Headquartered in Rotorua, New Zealand, NZ Hemp Brokers have quickly grown to become one of the country’s most trusted industrial hemp wholesalers, and New Zealand’s only import/export broker specialising in hemp products. NZ Hemp Brokers is licensed by the NZ Ministry of Health to grow, trade in and process industrial hemp, are registered brokers and certified in hemp medicine by the NZ Hemp Foundation.

ON BEHALF OF THE BOARD OF DIRECTORS
EASTWEST BIOSCIENCE GROUP

“Rodney Gelineau”
Co-Founder, Chief Executive Officer and Director

TSXV – Symbol: EAST

Company Website: www.eastwestbioscience.com
Contact: Nicholas Vincent – Investor Relations on 1-800-409-1930 or investors@eastwestscience.com.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the terms and conditions of the Acquisition. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; and delay or failure to receive board, shareholder or regulatory approvals. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: EastWest Bioscience Inc.

ReleaseID: 549527

IRVINE, CA / ACCESSWIRE / June 24, 2019 / Terra Tech Corp. (TRTC) (“Terra Tech”) or (the “Company”), a vertically integrated cannabis-focused agriculture company, today announced that all of its currently operating California facilities have been issued a provisional license from the State of California, which is valid for one year and requires METRC compliance. The issuance of these licenses ensures that operations will continue in a lawful and uninterrupted manner for the next year.

Licenses are issued only after an exhaustive review of operational and corporate documents that provide assurance to the State of California that lawful and transparent operations are being conducted and verify transparency of financial and ownership information. Terra Tech is migrating its entire existing inventory into the Marijuana Enforcement Tracking Reporting Compliance (METRC) system, bringing all licensed activities into compliant operations.

Chief Executive Officer, Derek Peterson, said, “I would like to thank the State of California for recognizing our efforts to ensure transparency and regulatory compliance at all our locations, and for issuing these provisional licenses, including one for our recently renovated Oakland cultivation facility. We are proud to be using the METRC software system to record the inventory and movement of our cannabis products through the commercial supply chain; this system advances the State of California’s objectives to promote a regulated, safe and conscientious cannabis market so that consumers can be assured that the products they’re buying are safe.”

Terra Tech operates licensed retail dispensaries under the business name Blüm in Oakland, San Leandro, and Santa Ana; and licensed cultivation and distribution activities in Oakland.

To be added to the Terra Tech email distribution list, please email TRTC@kcsa.com with TRTC in the subject line.

About Terra Tech
Terra Tech Corp. (OTCQX: TRTC) operates through multiple subsidiary businesses including: Blüm, IVXX Inc., Edible Garden, and MediFarm LLC. Blüm’s retail and medical cannabis facilities provide the highest quality medical cannabis to patients who are looking for alternative treatments for their chronic medical conditions as well as premium cannabis to the adult-use market in Nevada and California. Blüm offers a broad selection of cannabis products including; flowers, concentrates and edibles through its multiple California and Nevada locations. IVXX, Inc. is a wholly-owned subsidiary of Terra Tech that produces cannabis-extracted products for regulated cannabis dispensaries throughout California and dispensaries in Nevada. The Company’s wholly-owned subsidiary, Edible Garden, cultivates a premier brand of local and sustainably grown hydroponic produce, sold through major grocery stores such as ShopRite, Walmart, Ahold, Aldi, Meijer, Kroger, Stop & Shop and others nationwide. Terra Tech’s MediFarm LLC subsidiaries are focused on medical and adult-use cannabis cultivation and permitting businesses throughout Nevada.

For more information about Blüm Retail Stores visit: http://letsblum.com
Visit us on Facebook @ https://www.facebook.com/terratechcorp/timeline
Follow us on Instagram @Letsblum
Follow us on Twitter @terratechcorp
For more information about Edible Garden visit: http://www.ediblegarden.com/
Visit Edible Garden on Facebook @ https://www.facebook.com/ediblefarms?fref=ts

Cautionary Language Concerning Forward-Looking Statements
Statements in this press release may be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipate”, “believe”, “estimate”, “expect”, “intend” and similar expressions, as they relate to Terra Tech Corp. (the “Company”) or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the Company’s business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in the Company’s filings with the Securities and Exchange Commission. Any forward-looking statements speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after such date.

Contact
Philip Carlson
KCSA Strategic Communications
TRTC@kcsa.com
212-896-1238

SOURCE: Terra Tech Corp.

ReleaseID: 549558

LOS ANGELES, CA / ACCESSWIRE / June 24, 2019 / Compare-autoinsurance.org has launched a new blog post that presents several methods to lower car insurance rates.

For more info and free car insurance quotes online, visit https://compare-autoinsurance.org/how-to-make-car-insurance-rates-cheaper/

Car insurance companies determine the premium paid by a driver after analyzing multiple factors. Some of these factors are under policyholder’s control and can help him get cheaper car insurance.

Adjust the deductibles. Drivers can increase the deductibles levels to lower the price of their insurance rate. In many cases, the premium rates drop as much as 30%. Policyholders should consider adjusting the deductibles to a level they can support if something bad happens.

Consider dropping medical payments coverage. If a policyholder already has health insurance, then he will not need the medical payments coverage. In most cases, the two policies overlap.

Policyholders should consider buying a cheaper car to insure. Cars that are considered safe and come equipped with safety features and anti-theft devices are cheaper to insure.

Consider the low mileage discount. If a policyholder doesn’t drive his car too often, he might be eligible for a low mileage discount that typically ranges from 15% to 20%.

Bundle policies. Insurance companies offer substantial discounts to those policyholders that choose to bundle policies. Policyholders can choose to bundle at least two vehicles policies or their vehicle policy can be bundled with their home insurance policy.

Look for additional discounts. Insurance companies offer plenty of discounts, like a senior citizen discount, loyalty discount, good driver discount, good student discount. Policyholders should check for what discounts may apply.

For additional info, money-saving tips and free car insurance quotes, visit https://compare-autoinsurance.org/

Compare-autoinsurance.org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc.

“Smart drivers can get cheaper auto policies, by
following several smart methods”, said Russell Rabichev,
Marketing Director of Internet Marketing Company.

Contact: cgurgu@internetmarketingcompany.biz

SOURCE: Internet Marketing Company

ReleaseID: 549639

KING OF PRUSSIA, PA / ACCESSWIRE / June 24, 2019 / Emergent Health Corp. (the “Company”) (OTC PINK: EMGE) purpose of this Press Release is to bring shareholders to date:

The Company is pleased to announce continued growth of its JDI Life Division www.jdi.jdilife.com . Based upon a past and possible continued growth of 10 to 20% per month, this Division could grow up to $160,000 per month by June, 2021 if at 10% per month and up to $160,000 per month by August 2020 if at 20% per month. Should this growth continue, the Company intends to convert this Division into a subsidiary and to eventually have it become a public company.
Emergent Medical Foods, Inc., a WY corporation (the “Medical Food Sub”), is a subsidiary of the Company. The Medical Food Sub is in process of raising private equity from collaborative investors to move this endeavor forward. To explain how much of a Disruptor this product can be, this video was produced: Emergent Medical food Video.mp4 The Medical Food Sub is licensed to market a patented NutraCan™ product as a medical food for Nutritional Support for Cancer patients. Preliminary work to further test this product is in development. The Medical Food Sub intends to become a publicly traded company at some future time, if and when successful. The Company intends to release more information about the Medical Food Sub in the future. Nothing stated about the Medical Food Sub is intended to diagnose, treat, prevent or cure any disease.
The Company Founder has invented certain new and useful improvements in Relieving Stress, for which was filed on June 18, 2019 a provisional patent application in the United States under application no. 62/862730. The intention is to license the Company to market the innovations of this patent which could be beneficial to those with unresolved stress. The product is intended to be called Anxium™ Stress Reliever. The global anxiety disorder market is in excess of $6 billion. Nothing stated about the Anxium™ product is intended to diagnose, treat, prevent or cure any disease
The Company continues to move ahead in the process of developing a reverse Berkshire Hathaway (NYSE:BRK-A) business model as explained previously. This proven “start-up” model was developed by Thermo Electron, which is now Thermo Fisher Scientific Inc. (NYSE:TMO). As with Thermo Electron, each subsidiary is expected to raise its own capital and have an independent valuation. It thus acts as a “pure play” and contributes book value and a revenue base to the Company.
The Company has at this time purchased 73,100 free trading shares of its current free trading shares of 2,120,594 shares in CEDE (Street Name). The remaining 52,809,406 shares and future shares which are not in Street Name are not eligible for conversion to Street Name until the Company has Current Information posted at OTC Markets. At such time the Company is considering working with its shareholders to establish some kind of registered liquidity event if and when the market becomes more liquid, and if feasible.
The Company continues to work diligently towards current status on OTC Markets. New Advisory Board Members will also be introduced over the next 90 days.

The Company hopes shareholders will find this Press Release informative as to its intentions.

About Emergent Health Corp.

Emergent Health Corp., a diversified biotechnology firm, is focused on the health and wellness industry. With patented, patent pending and proprietary nutritionally designed products, Emergent believes it is positioning itself as a leader in the fields of Regenerative Medicine and/or Health as defined by the National Institute of Health.

This press release contains certain “forward-looking” statements, defined in the United States Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are estimates reflecting the company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors that could cause actual results to differ materially from those estimated by the company.

This press release is provided for information purposes only and is not intended to constitute an offer to sell or a solicitation of an offer to buy securities.

CONTACT:

Emergent Health Corp.
Investor Relations
484-518-9000

SOURCE: Emergent Health Corp.

ReleaseID: 549500

National Retailer Has Over 1,500 Locations for Potential Installs

PHOENIX, AZ / ACCESSWIRE / June 24, 2019 / Taronis Technologies, Inc., (“Taronis” or “the Company”) (NASDAQ: TRNX), a leading clean technology company in the renewable resources and environmental conservation industry, today announced a new pilot test phase contract for multiple parent-company locations with a top US retailer. The client has requested that its identity remain confidential during this test phase.

The initial pilot phase installation is expected to be completed at multiple parent-company owned locations during the third quarter. The test phase is intended to generate sufficient data for the prospective client to evaluate moving forward with a scalable contract within the remainder of 2019.

The Water Pilot® System is designed to immediately reduce water consumption and provide installed customers with live remote consumption monitoring for long term leak protection and water asset management. Water Pilot has the potential to benefit a wide range of businesses or property with a water meter, including hotels and hospitality, elder and nursing care facilities, restaurants, retail, apartment complexes and other scaled commercial and residential properties.

Our team at the Water Pilot is building meaningful momentum with prospective clients,” commented Scott Mahoney, CEO of Taronis. “In the past month, our new team has executed with an impressive sense of urgency. They have made solid progress with several potentially scalable client relationships, and we are optimistic that with the added resources of Taronis, they can quickly begin to convert some of these relationships into impactful revenues for our Company.”

About Taronis Technologies, Inc.

Taronis Technologies, Inc. (TRNX) owns a patented plasma arc technology that enables two primary end use applications for fuel generation and water decontamination.

The Company’s fuel technology enables a wide use of hydrocarbon feedstocks to be readily converted to fossil fuel substitutes. The Company is developing a wide range of end market uses for these fuels, including replacement products for propane, compressed natural gas and liquid natural gas. The Company currently markets a proprietary metal cutting fuel that is highly competitive with acetylene. The Company distributes its proprietary metal cutting fuel through Independent Distributors in the U.S and through its wholly owned distributors doing business as “MagneGas Welding Supply”. The Company operates 22 locations across California, Texas, Louisiana, and Florida.

The Company’s technology can also be implemented for the decontamination of waste water, including sterilizing water, eradicating all pathogens. The technology is being tested to determine if it can completely eliminate pharmaceutical contaminants such as antibiotics, hormones and other soluble drugs suspended in contaminated water. Lastly, the technology process is capable of reducing or eliminating other contaminants, such as harmful metals, as well as nitrogen, phosphorus, and potassium levels that trigger toxic algae blooms. The technology has prospective commercial applications in the agricultural, pharmaceutical, and municipal waste markets. For more information on Taronis, please visit the Company’s website at http://www.TaronisTech.com.

Taronis also owns a controlling interest in Water Pilot, LLC. The WATER PILOT® System immediately reduces water consumption and provides you with live remote consumption monitoring for long term leak protection and water asset management. An integral, client based alarm and notification system that reports to any mobile device. Water Pilot is appropriate for every business or property with a water meter. For more information, please visit our website at www.gowaterpilot.com/.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

For a discussion of these risks and uncertainties, please see our filings with the Securities and Exchange Commission. Our public filings with the SEC are available from commercial document retrieval services and at the website maintained by the SEC at http://www.sec.gov.

Investor Contacts:

Tyler Wilson
IR@TaronisTech.com

SOURCE: Taronis Technologies, Inc.

ReleaseID: 549534